查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1989126

口腔微生物組市場預測至2034年－按產品類型、技術、應用、最終用戶、通路、人口統計和地區分類的全球分析

Oral Microbiome Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Application, End User, Distribution Channel, Demographics, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球口腔微生物組市場將達到 11.4 億美元，在預測期內以 15.9% 的複合年成長率成長，到 2034 年將達到 37.1 億美元。

口腔微生物組市場專注於了解和調控口腔內複雜的微生物生態系統，以改善口腔和全身健康。科學知識的進步揭示了口腔細菌與全身性疾病之間的聯繫，這些疾病不僅包括牙周病，還包括心血管疾病、糖尿病和阿茲海默症，這正推動著標靶治療和診斷技術的創新。這一新興領域涵蓋益生菌製劑、診斷測試、基於微生物組的治療方法以及旨在維持微生物平衡的專用口腔清潔用品。

越來越多的科學證據顯示口腔健康與全身性疾病有關

隨著越來越多的研究顯示口腔微生物群組成與整體健康密切相關，口腔微生物群市場的重要性正超越牙科護理的範疇。研究表明，牙周病原體與心血管疾病、不良懷孕結果和呼吸道感染疾病之間存在關聯，這為消費者和醫療保健專業人員重視口腔微生物平衡提供了強力的理由。這種更廣泛的健康視角將口腔清潔用品從單純的美容問題提升為重要的健康維護措施，從而推動了對支持有益菌叢產品的需求。醫療保健專業人員擴大推薦注重微生物群的口腔清潔用品產品，並透過專業管道和相關人員擴大市場覆蓋範圍。

產品分類中的監管複雜性

口腔微生物組產品監管政策的不明確是其市場准入的一大障礙，也為商業化帶來了許多挑戰。根據功效聲明和配方，調節微生物組的產品可能被歸類為化妝品、膳食補充劑、醫療設備或藥品，而每種產品都需要不同的核准流程。這種監管上的模糊性增加了研發成本，延長了產品上市時間，並為生產商帶來了合規風險。國際監管標準的不統一進一步加劇了全球商業化策略的複雜性。尤其是小規模的創新公司，即使擁有強力的科學證據和消費者興趣，也難以滿足這些複雜的監管要求，這可能會限制產品多樣性並減緩整體市場成長。

將人工智慧整合到微生物組分析中

人工智慧驅動的平台能夠分析複雜的口腔微生物組數據，為個人化口腔清潔用品建議帶來創新機會。機器學習演算法可以識別與特定疾病風險相關的微生物模式，從而實現預測性診斷和標靶干預。這些技術能夠處理來自定序和代謝體學的大量資料集，為消費者和牙科專業人士提供可操作的見解。人工智慧的整合加速了基於微生物組的療法的伴隨診斷的開發，從而實現即時治療最佳化。隨著運算能力的提升和成本的降低，人工智慧驅動的個人化口腔健康解決方案正變得越來越普及，為更廣泛的用戶群創造了巨大的市場拓展機會。

傳統牙科專業人士的懷疑態度

傳統牙科專業人士的抵觸情緒會影響患者的認知和治療建議，進而威脅市場滲透。許多牙科專業人士對微生物組科學並不熟悉，或對益生菌口腔保健方法持懷疑態度，更傾向於採用現有的機械和化學干預措施。這種懷疑態度限制了專業人士的推薦和轉診，進而顯著影響患者對新產品的接受度。如果得不到牙科界的支持，微生物組產品可能會被視為缺乏依據的健康潮流，而非循證治療方案，從而阻礙市場滲透，並延緩其融入標準口腔清潔用品通訊協定和專業建議的過程。

新冠疫情的影響：

新冠疫情提高了人們對免疫健康與微生物平衡之間聯繫的認知，從而帶動了口腔微生物組市場的發展。消費者越來越意識到口腔是病原體進入人體的途徑之一，因此對增強口腔免疫力的產品需求日益成長。疫情封鎖期間遠距牙科服務的普及，使患者熟悉了遠端口腔健康管理，也為推薦以微生物組為基礎的產品創造了管道。然而，疫情導致的牙科就診中斷，暫時減少了專業人士提供樣品和建議的機會。從長遠來看，消費者對預防性口腔健康管理的持續關注以及對數位化醫療方式的接受度，都將推動市場持續成長。

在預測期內，口腔護理產品細分市場預計將佔據最大的市場佔有率。

在預測期內，口腔護理產品預計將佔據最大的市場佔有率。此細分市場包括牙膏、漱口水以及旨在支持口腔有益菌叢的特殊配方產品。這些產品在保留傳統清潔功能的同時，融入了有益於口腔微生物群的成分，使消費者能夠在不改變現有習慣的情況下提升口腔護理效果。領先的口腔護理品牌正透過利用其成熟的分銷管道和消費者信任，並拓展產品線，進軍這一細分市場。該細分市場憑藉其日常使用習慣和廣泛的受眾群體而佔據優勢，隨著微生物組科學融入傳統口腔護理，有望保持其持續的市場領導地位。

預計在預測期內，次世代定序（NGS）領域將呈現最高的複合年成長率。

在預測期內，次世代定序(NGS) 技術預計將呈現最高的成長速度，從而以前所未有的精度和深度對口腔微生物組進行全面分析。 NGS 技術能夠識別與健康和疾病相關的細菌種類和菌株，為診斷應用和治療方法的開發提供支援。定序成本的不斷降低使得這項技術越來越容易應用於臨床和直接面對消費者 (DTC) 的領域。牙科專業人士正在利用基於 NGS 的檢測來制定個人化的治療方案，而研究人員則正在使用這些工具進行微生物組探索。該技術在推進診斷和治療方面發揮的關鍵作用，正是其顯著成長的驅動力。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的牙科醫療保健基礎設施、較高的消費者意識以及對研發的大量投入。該地區擁有領先的微生物組研究機構和許多致力於將科學發現商業化的創新Start-Ups。強大的D2C（直接面對消費者）行銷管道以及消費者對新型健康產品的接受度正在加速市場滲透。牙科保險對預防保健的覆蓋範圍以及專家對微生物組相關產品的推薦，進一步促進了產品的普及。研究人員、臨床醫生和製造商之間建立的穩固關係，構成了一個創新生態系統，這將使北美在整個預測期內保持市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於其龐大的人口基數、不斷提高的口腔健康意識以及中產階級獲得高品質口腔清潔用品的管道日益增多。在中國、日本和韓國等國家，傳統的預防醫學概念與先進健康技術的快速普及相結合，同時，隨著牙科旅遊的興起和國際訊息的廣泛傳播，消費者對微生物組概念的了解也日益加深。政府促進醫療保健的措施以及不斷成長的醫療保健支出，都為市場基礎設施​​的建設提供了支持。隨著國際微生物組公司拓展經銷夥伴，以及本地製造商開發針對該地區的產品，亞太地區正崛起為成長最快的區域市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球口腔微生物組市場：依產品類型分類

  • 含有益生菌的口腔清潔用品
  • 益生元口腔清潔用品
  • 共生製劑
  • 口腔微生物組診斷與檢測套組
  • 以微生物組為基礎的療法
  • 口腔清潔用品
  • 營養補充品
  • 其他產品類型

第6章 全球口腔微生物組市場：依技術分類

  • 次世代定序（NGS）
  • 總體基因體學
  • 宏轉錄組學
  • 蛋白質體學和代謝體學
  • 生物資訊學和微生物組分析
  • 人工智慧驅動的微生物組建模
  • 其他技術

第7章 全球口腔微生物組市場：依應用分類

  • 預防蛀牙
  • 牙周病
  • 口臭治療方法
  • 口腔癌檢測和風險評估
  • 與系統性疾病的關聯
  • 個人化口腔護理
  • 預防牙科
  • 其他用途

第8章 全球口腔微生物組市場：依最終用戶分類

  • 牙醫診所
  • 醫院
  • 研究和學術機構
  • 診斷檢查室
  • 製藥和生物技術公司
  • 個人消費者
  • 其他最終用戶

第9章 全球口腔微生物組市場：依通路分類

  • 線上平台
  • 藥局和藥局
  • 牙醫診所和醫院
  • 專賣店
  • 直接面對消費者的銷售管道
  • 其他分銷管道

第10章 全球口腔微生物組市場：依人口統計群分類

  • 成人
  • 兒童
  • 老年人口

第11章 全球口腔微生物組市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Colgate-Palmolive Company
  • Procter & Gamble Company
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Unilever PLC
  • 3M Company
  • Dentsply Sirona Inc.
  • Kao Corporation
  • Lion Corporation
  • Sunstar Suisse SA
  • Oragenics, Inc.
  • BLIS Technologies Limited
  • Oral Biotech Ltd.
  • Microbiome Insights Inc.
  • Viome Life Sciences, Inc.
Product Code: SMRC34415

According to Stratistics MRC, the Global Oral Microbiome Market is accounted for $1.14 billion in 2026 and is expected to reach $3.71 billion by 2034 growing at a CAGR of 15.9% during the forecast period. The oral microbiome market focuses on understanding and modulating the complex ecosystem of microorganisms residing in the oral cavity to improve dental and systemic health. Scientific advances linking oral bacteria to conditions beyond gum disease including cardiovascular disorders, diabetes, and Alzheimer's are driving innovation in targeted therapeutics and diagnostics. This emerging field encompasses probiotic formulations, diagnostic testing, microbiome-based therapeutics, and specialized oral care products designed to maintain microbial balance.

Market Dynamics:

Driver:

Growing scientific evidence linking oral health to systemic diseases

Accumulating research establishing connections between oral microbiome composition and overall health conditions is expanding market relevance beyond dentistry. Studies demonstrating associations between periodontal pathogens and cardiovascular disease, adverse pregnancy outcomes, and respiratory infections create compelling reasons for consumers and healthcare providers to prioritize oral microbial balance. This broader health context elevates oral care from cosmetic concern to essential wellness practice, driving demand for products supporting beneficial bacterial populations. Healthcare professionals increasingly recommend microbiome-friendly oral care, expanding market reach through professional channels and medical endorsement.

Restraint:

Regulatory complexities in product classification

Uncertain regulatory pathways for oral microbiome products create significant market entry barriers and commercialization challenges. Products modulating microbial populations may face classification as cosmetics, dietary supplements, medical devices, or drugs depending on claims and formulations, each requiring different approval processes. This regulatory ambiguity increases development costs, extends time-to-market, and creates compliance risks for manufacturers. Inconsistent international regulations further complicate global commercialization strategies. Smaller innovators particularly struggle with navigating these complex requirements, potentially limiting product diversity and slowing overall market expansion despite strong scientific foundations and consumer interest.

Opportunity:

Integration of artificial intelligence in microbiome analysis

AI-powered platforms analyzing complex oral microbiome data present transformative opportunities for personalized oral care recommendations. Machine learning algorithms can identify microbial patterns associated with specific disease risks, enabling predictive diagnostics and targeted interventions. These technologies process vast datasets from sequencing and metabolomics to generate actionable insights for consumers and dental professionals. AI integration facilitates development of companion diagnostics for microbiome therapeutics and enables real-time treatment optimization. As computational capabilities advance and costs decrease, AI-driven personalized oral health solutions become accessible to broader populations, creating substantial market expansion opportunities.

Threat:

Skepticism from traditional dental professionals

Resistance from conventional dentistry practitioners threatens market adoption by influencing patient perceptions and treatment recommendations. Many dental professionals remain unfamiliar with microbiome science or skeptical of probiotic approaches to oral health, preferring established mechanical and chemical interventions. This skepticism limits professional endorsements and referrals that significantly influence patient acceptance of novel products. Without dental community support, microbiome products risk being perceived as unsubstantiated wellness trends rather than evidence-based therapeutic options, constraining market penetration and delaying integration into standard oral care protocols and professional recommendations.

Covid-19 Impact:

The COVID-19 pandemic heightened awareness of immune health and its connection to microbial balance, benefiting oral microbiome market interest. Consumers increasingly recognized oral cavity as entry point for pathogens, driving interest in products supporting oral immune defenses. Tele-dentistry expansion during lockdowns familiarized patients with remote oral health management, creating channels for microbiome-based product recommendations. However, pandemic-related disruptions to dental visits reduced professional sampling and recommendation opportunities temporarily. The lasting legacy includes sustained consumer interest in proactive oral health management and acceptance of digital health approaches supporting continued market growth.

The Oral Care Products segment is expected to be the largest during the forecast period

The Oral Care Products segment is expected to account for the largest market share during the forecast period, encompassing toothpastes, mouthwashes, and specialized formulations designed to support beneficial oral bacteria. These products integrate microbiome-friendly ingredients while maintaining traditional cleaning functions, allowing consumers to upgrade existing routines without behavioral changes. Major oral care brands have entered this segment through product line extensions, leveraging established distribution channels and consumer trust. The segment benefits from daily usage patterns and broad demographic appeal, ensuring sustained market leadership as microbiome science integrates into conventional oral care.

The Next-Generation Sequencing (NGS) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Next-Generation Sequencing (NGS) segment is predicted to witness the highest growth rate, enabling comprehensive profiling of oral microbial communities with unprecedented accuracy and depth. NGS technology allows identification of bacterial species and strains associated with health and disease, supporting diagnostic applications and therapeutic development. Decreasing sequencing costs make this technology increasingly accessible for clinical and direct-to-consumer applications. Dental professionals utilize NGS-based testing for personalized treatment planning, while researchers employ these tools for microbiome discoveries. The segment's essential role in advancing both diagnostics and therapeutics drives exceptional growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced dental healthcare infrastructure, high consumer awareness, and significant research investment. The region hosts leading microbiome research institutions and innovative startups commercializing scientific discoveries. Strong direct-to-consumer marketing channels and consumer willingness to adopt novel wellness products accelerate market penetration. Dental insurance coverage for preventive care and professional recommendations for microbiome-based products further drive adoption. Established relationships between researchers, clinicians, and manufacturers create an innovation ecosystem maintaining North America's dominant market position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by large populations, rising dental health awareness, and expanding middle-class access to premium oral care. Countries including China, Japan, and South Korea combine traditional appreciation for preventive health with rapid adoption of advanced wellness technologies. Increasing dental tourism and international exposure familiarize consumers with microbiome concepts. Government initiatives promoting preventive healthcare and rising healthcare expenditure support market infrastructure development. As international microbiome companies expand distribution partnerships and local manufacturers develop regionally relevant products, Asia Pacific emerges as the fastest-growing regional market.

Key players in the market

Some of the key players in Oral Microbiome Market include Colgate-Palmolive Company, Procter & Gamble Company, Johnson & Johnson, GlaxoSmithKline plc, Unilever PLC, 3M Company, Dentsply Sirona Inc., Kao Corporation, Lion Corporation, Sunstar Suisse S.A., Oragenics, Inc., BLIS Technologies Limited, Oral Biotech Ltd., Microbiome Insights Inc., and Viome Life Sciences, Inc.

Key Developments:

In January 2026, Colgate-Palmolive announced a new multi-year global partnership with the WHO Foundation to advance oral health. The initiative focuses on scaling preventive measures and education, recognizing oral diseases as a foundational public health priority linked to overall systemic health.

In July 2025, Haleon broke ground on a new £130 million Global Oral Health Innovation Centre in Weybridge, UK. This facility is dedicated to R&D in dental science, including the study of oral biofilms and their impact on systemic health.

In May 2025, Unilever scientists, in collaboration with the University of Liverpool, published a study in the British Journal of Dermatology regarding the microbiome-brain axis. While focused on skin, the company confirmed this research is being applied to its oral care portfolio (Zendium brand) to understand the link between oral bacteria and psychological wellbeing.

Product Types Covered:

  • Probiotic-Based Oral Products
  • Prebiotic Oral Products
  • Synbiotic Formulations
  • Oral Microbiome Diagnostics & Test Kits
  • Microbiome-Based Therapeutics
  • Oral Care Products
  • Dietary Supplements
  • Other Product Types

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Metagenomics
  • Metatranscriptomics
  • Proteomics & Metabolomics
  • Bioinformatics & Microbiome Analytics
  • AI-Based Microbiome Modeling
  • Other Technologies

Applications Covered:

  • Dental Caries Prevention
  • Periodontal Diseases
  • Halitosis Management
  • Oral Cancer Detection & Risk Assessment
  • Systemic Disease Link
  • Personalized Oral Healthcare
  • Preventive Dentistry
  • Other Applications

End Users Covered:

  • Dental Clinics
  • Hospitals
  • Research & Academic Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Individual Consumers
  • Other End Users

Distribution Channels Covered:

  • Online Platforms
  • Pharmacies & Drug Stores
  • Dental Clinics & Hospitals
  • Specialty Stores
  • Direct-to-Consumer Channels
  • Other Distribution Channels

Demographics Covered:

  • Adults
  • Pediatrics
  • Geriatric Population

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Oral Microbiome Market, By Product Type

  • 5.1 Probiotic-Based Oral Products
  • 5.2 Prebiotic Oral Products
  • 5.3 Synbiotic Formulations
  • 5.4 Oral Microbiome Diagnostics & Test Kits
  • 5.5 Microbiome-Based Therapeutics
  • 5.6 Oral Care Products
  • 5.7 Dietary Supplements
  • 5.8 Other Product Types

6 Global Oral Microbiome Market, By Technology

  • 6.1 Next-Generation Sequencing (NGS)
  • 6.2 Metagenomics
  • 6.3 Metatranscriptomics
  • 6.4 Proteomics & Metabolomics
  • 6.5 Bioinformatics & Microbiome Analytics
  • 6.6 AI-Based Microbiome Modeling
  • 6.7 Other Technologies

7 Global Oral Microbiome Market, By Application

  • 7.1 Dental Caries Prevention
  • 7.2 Periodontal Diseases
  • 7.3 Halitosis Management
  • 7.4 Oral Cancer Detection & Risk Assessment
  • 7.5 Systemic Disease Link
  • 7.6 Personalized Oral Healthcare
  • 7.7 Preventive Dentistry
  • 7.8 Other Applications

8 Global Oral Microbiome Market, By End User

  • 8.1 Dental Clinics
  • 8.2 Hospitals
  • 8.3 Research & Academic Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Pharmaceutical & Biotechnology Companies
  • 8.6 Individual Consumers
  • 8.7 Other End Users

9 Global Oral Microbiome Market, By Distribution Channel

  • 9.1 Online Platforms
  • 9.2 Pharmacies & Drug Stores
  • 9.3 Dental Clinics & Hospitals
  • 9.4 Specialty Stores
  • 9.5 Direct-to-Consumer Channels
  • 9.6 Other Distribution Channels

10 Global Oral Microbiome Market, By Demographics

  • 10.1 Adults
  • 10.2 Pediatrics
  • 10.3 Geriatric Population

11 Global Oral Microbiome Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Colgate-Palmolive Company
  • 14.2 Procter & Gamble Company
  • 14.3 Johnson & Johnson
  • 14.4 GlaxoSmithKline plc
  • 14.5 Unilever PLC
  • 14.6 3M Company
  • 14.7 Dentsply Sirona Inc.
  • 14.8 Kao Corporation
  • 14.9 Lion Corporation
  • 14.10 Sunstar Suisse S.A.
  • 14.11 Oragenics, Inc.
  • 14.12 BLIS Technologies Limited
  • 14.13 Oral Biotech Ltd.
  • 14.14 Microbiome Insights Inc.
  • 14.15 Viome Life Sciences, Inc.

List of Tables

  • Table 1 Global Oral Microbiome Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Oral Microbiome Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Oral Microbiome Market Outlook, By Probiotic-Based Oral Products (2023-2034) ($MN)
  • Table 4 Global Oral Microbiome Market Outlook, By Prebiotic Oral Products (2023-2034) ($MN)
  • Table 5 Global Oral Microbiome Market Outlook, By Synbiotic Formulations (2023-2034) ($MN)
  • Table 6 Global Oral Microbiome Market Outlook, By Oral Microbiome Diagnostics & Test Kits (2023-2034) ($MN)
  • Table 7 Global Oral Microbiome Market Outlook, By Microbiome-Based Therapeutics (2023-2034) ($MN)
  • Table 8 Global Oral Microbiome Market Outlook, By Oral Care Products (2023-2034) ($MN)
  • Table 9 Global Oral Microbiome Market Outlook, By Dietary Supplements (2023-2034) ($MN)
  • Table 10 Global Oral Microbiome Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 11 Global Oral Microbiome Market Outlook, By Technology (2023-2034) ($MN)
  • Table 12 Global Oral Microbiome Market Outlook, By Next-Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 13 Global Oral Microbiome Market Outlook, By Metagenomics (2023-2034) ($MN)
  • Table 14 Global Oral Microbiome Market Outlook, By Metatranscriptomics (2023-2034) ($MN)
  • Table 15 Global Oral Microbiome Market Outlook, By Proteomics & Metabolomics (2023-2034) ($MN)
  • Table 16 Global Oral Microbiome Market Outlook, By Bioinformatics & Microbiome Analytics (2023-2034) ($MN)
  • Table 17 Global Oral Microbiome Market Outlook, By AI-Based Microbiome Modeling (2023-2034) ($MN)
  • Table 18 Global Oral Microbiome Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 19 Global Oral Microbiome Market Outlook, By Application (2023-2034) ($MN)
  • Table 20 Global Oral Microbiome Market Outlook, By Dental Caries Prevention (2023-2034) ($MN)
  • Table 21 Global Oral Microbiome Market Outlook, By Periodontal Diseases (2023-2034) ($MN)
  • Table 22 Global Oral Microbiome Market Outlook, By Halitosis Management (2023-2034) ($MN)
  • Table 23 Global Oral Microbiome Market Outlook, By Oral Cancer Detection & Risk Assessment (2023-2034) ($MN)
  • Table 24 Global Oral Microbiome Market Outlook, By Systemic Disease Link (2023-2034) ($MN)
  • Table 25 Global Oral Microbiome Market Outlook, By Personalized Oral Healthcare (2023-2034) ($MN)
  • Table 26 Global Oral Microbiome Market Outlook, By Preventive Dentistry (2023-2034) ($MN)
  • Table 27 Global Oral Microbiome Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 28 Global Oral Microbiome Market Outlook, By End User (2023-2034) ($MN)
  • Table 29 Global Oral Microbiome Market Outlook, By Dental Clinics (2023-2034) ($MN)
  • Table 30 Global Oral Microbiome Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 31 Global Oral Microbiome Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 32 Global Oral Microbiome Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 33 Global Oral Microbiome Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 34 Global Oral Microbiome Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 35 Global Oral Microbiome Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 36 Global Oral Microbiome Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 37 Global Oral Microbiome Market Outlook, By Online Platforms (2023-2034) ($MN)
  • Table 38 Global Oral Microbiome Market Outlook, By Pharmacies & Drug Stores (2023-2034) ($MN)
  • Table 39 Global Oral Microbiome Market Outlook, By Dental Clinics & Hospitals (2023-2034) ($MN)
  • Table 40 Global Oral Microbiome Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 41 Global Oral Microbiome Market Outlook, By Direct-to-Consumer Channels (2023-2034) ($MN)
  • Table 42 Global Oral Microbiome Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 43 Global Oral Microbiome Market Outlook, By Demographics (2023-2034) ($MN)
  • Table 44 Global Oral Microbiome Market Outlook, By Adults (2023-2034) ($MN)
  • Table 45 Global Oral Microbiome Market Outlook, By Pediatrics (2023-2034) ($MN)
  • Table 46 Global Oral Microbiome Market Outlook, By Geriatric Population (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.